The PAC-SYM questionnaire for chronic constipation: Defining the minimal important difference. Aliment. Pharmacol. Ther. 2017, 46, 1103-1111. [CrossRef] [PubMed]
Validation of the PAC-SYM questionnaire for opioid-induced consti- pation in patients with chronic low back pain. Eur J Pain 2006; 10: 209-217.Slappendel R; Simpson K; Dubois D;.Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain....
183-184 - 703 VALIDATION OF THE PAC-SYM QUESTIONNAIRE IN A NON-CANCER PAIN POPULATION RECEIVING ALVIMOPAN FOR OPIOID-INDUCED GASTROINTESTINAL (GI) SIDE EFFECTS - EM|consultedoi:10.1016/S1090-3801(06)60706-4T. TuskerFellbacher Str. Fellbach, GermanyC. Wachter...
703 VALIDATION OF THE PAC-SYM QUESTIONNAIRE IN A NON-CANCER PAIN POPULATION RECEIVING ALVIMOPAN FOR OPIOID-INDUCED GASTROINTESTINAL (GI) SIDE EFFECTSdoi:10.1016/S1090-3801(06)60706-4T.FellbacherTuskerFellbacherC.FellbacherWachterFellbacherB.Fellbacher...
Effect of Methylnaltrexone SC on Constipation Symptoms Using the Patient Assessment of Constipation Symptoms (PAC-SYM) Questionnaire in Patients with Chronic Non-Malignant Pain and Opioid-Induced Constipation: 2009 Presidential Poster: 1092Iyer, Shrividya...
(892): Severity of constipation-associated GI symptoms related to opioid treatment in chronic pain patients: PAC-SYM questionnaire results from the OPIOID surveyJournal of Pain, The - Vol. 8 - N° 4S - p. 71 - (883) : Impact on quality of life of constipation-associated GI symptoms ...